Outpatient Management of Fever and Neutropenia in Low-risk Children with Solid Tumors: A Quality Improvement Initiative.

IF 1.2 Q3 PEDIATRICS
Pediatric quality & safety Pub Date : 2024-09-25 eCollection Date: 2024-09-01 DOI:10.1097/pq9.0000000000000771
Wallace Bourgeois, Jonathan Paolino, Riley Garland, Kevin Campbell, Francesca Alvarez-Calderon, A Lindsay Frazier, Allison F O'Neill, Maya Ilowite, Chris I Wong
{"title":"Outpatient Management of Fever and Neutropenia in Low-risk Children with Solid Tumors: A Quality Improvement Initiative.","authors":"Wallace Bourgeois, Jonathan Paolino, Riley Garland, Kevin Campbell, Francesca Alvarez-Calderon, A Lindsay Frazier, Allison F O'Neill, Maya Ilowite, Chris I Wong","doi":"10.1097/pq9.0000000000000771","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Management of febrile neutropenia in pediatric oncology usually requires inpatient parenteral antibiotics after initial evaluation, but some patients at lower risk of sepsis could be safely managed outpatient. We describe a quality improvement project to increase outpatient management of fever and neutropenia.</p><p><strong>Methods: </strong>We designed a standardized algorithm for children with a solid tumor diagnosis and low risk for bacteremia. The aim was to achieve outpatient management for at least 80% of eligible patients within 20 months of project initiation. We used plan-do-study-act cycles to improve algorithm compliance, including optimizing medical record decision support, developing targeted educational materials and outreach, and restructuring outpatient processes to allow for close follow-up. We surveyed patients (age ≥12 y) and parents/caregivers to assess the impact of outpatient management.</p><p><strong>Results: </strong>The initiative led to 71% (n = 34) of eligible patients being managed as outpatients. Six percent (n = 2) of patients developed bacteremia, resulting in hospital admission. Fifteen of 26 parents/caregivers and five of 11 patients approached completed the survey. For the preferred setting of febrile neutropenia management, 83% of patients preferred to be home versus 40% of parents/caregivers. No patient expressed any of the three highest ratings in the question exploring fear regarding outpatient febrile neutropenia management versus 67% of parents/caregivers.</p><p><strong>Conclusions: </strong>Some children with a solid tumor diagnosis at low risk for bacteremia are safely managed for febrile neutropenia as outpatients. Targeted efforts to engage parents/caregivers early in this practice change are necessary for success.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11424129/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric quality & safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/pq9.0000000000000771","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Management of febrile neutropenia in pediatric oncology usually requires inpatient parenteral antibiotics after initial evaluation, but some patients at lower risk of sepsis could be safely managed outpatient. We describe a quality improvement project to increase outpatient management of fever and neutropenia.

Methods: We designed a standardized algorithm for children with a solid tumor diagnosis and low risk for bacteremia. The aim was to achieve outpatient management for at least 80% of eligible patients within 20 months of project initiation. We used plan-do-study-act cycles to improve algorithm compliance, including optimizing medical record decision support, developing targeted educational materials and outreach, and restructuring outpatient processes to allow for close follow-up. We surveyed patients (age ≥12 y) and parents/caregivers to assess the impact of outpatient management.

Results: The initiative led to 71% (n = 34) of eligible patients being managed as outpatients. Six percent (n = 2) of patients developed bacteremia, resulting in hospital admission. Fifteen of 26 parents/caregivers and five of 11 patients approached completed the survey. For the preferred setting of febrile neutropenia management, 83% of patients preferred to be home versus 40% of parents/caregivers. No patient expressed any of the three highest ratings in the question exploring fear regarding outpatient febrile neutropenia management versus 67% of parents/caregivers.

Conclusions: Some children with a solid tumor diagnosis at low risk for bacteremia are safely managed for febrile neutropenia as outpatients. Targeted efforts to engage parents/caregivers early in this practice change are necessary for success.

低风险儿童实体瘤患者发热和中性粒细胞减少的门诊管理:质量改进计划。
背景:儿科肿瘤中的发热性中性粒细胞减少症通常需要在初步评估后住院肠外抗生素治疗,但一些脓毒症风险较低的患者可以在门诊安全治疗。我们介绍了一项旨在提高发热和中性粒细胞减少症门诊治疗质量的改进项目:我们为确诊为实体瘤且菌血症风险较低的儿童设计了一套标准化算法。我们的目标是在项目启动后的 20 个月内,为至少 80% 符合条件的患者提供门诊治疗。我们采用 "计划-实施-研究-行动 "的循环方法来提高算法的依从性,包括优化病历决策支持、开发有针对性的教育材料和外联活动,以及调整门诊流程以进行密切随访。我们对患者(年龄≥12 岁)和家长/监护人进行了调查,以评估门诊管理的影响:结果:该举措使71%(n = 34)符合条件的患者接受了门诊管理。6%(n = 2)的患者出现菌血症,导致入院治疗。在接触的 26 位家长/监护人和 11 位患者中,分别有 15 位和 5 位完成了调查。对于发热性中性粒细胞减少症的首选治疗环境,83% 的患者选择在家,而 40% 的家长/护理人员选择在家。在探讨发热性中性粒细胞减少症门诊治疗的恐惧问题时,没有患者表示出三个最高评级中的任何一个,而家长/护理人员的这一比例为 67%:结论:一些确诊为实体瘤、菌血症风险较低的儿童在门诊接受发热性中性粒细胞减少症治疗是安全的。有针对性地让家长/护理人员尽早参与到这一实践变革中是成功的必要条件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信